Contact this trialFirst, we need to learn more about you.
SP-002 + Vismodegib for Basal Cell Carcinoma
Recruiting0 awardsPhase 2
Humble, Texas
This trial aims to see if adding SP-002 to current treatment for locally advanced Basal cell carcinoma is effective. They want to know the response rate of the tumors after 1 or 3 cycles
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service